We are live on
!
Find out more
MCM
McKinley Capital Management Portfolio holdings
AUM
$571M
1-Year Est. Return
36.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.2%
1 Year Est. Return
+36.44%
3 Year Est. Return
+63.3%
5 Year Est. Return
+224.69%
10 Year Est. Return
+867.52%
AUM
$2.07B
AUM Growth
-$4.51M
(-0.22%)
Cap. Flow
-$44.2M
Cap. Flow
% of AUM
-2.14%
Top 10 Holdings %
Top 10 Hldgs %
18.88%
Holding
520
New
183
Increased
97
Reduced
159
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$35.4M |
| 2 |
Amazon
AMZN
|
+$30.3M |
| 3 |
Zimmer Biomet
ZBH
|
+$27.2M |
| 4 |
Johnson & Johnson
JNJ
|
+$26.2M |
| 5 |
Newell Brands
NWL
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$34.7M |
| 2 |
American International
AIG
|
+$28.8M |
| 3 |
Microsoft
MSFT
|
+$27.1M |
| 4 |
AGN
Allergan plc
AGN
|
+$20.8M |
| 5 |
Keurig Dr Pepper
KDP
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.82% |
| 2 | Consumer Discretionary | 12.88% |
| 3 | Industrials | 11.98% |
| 4 | Technology | 11.97% |
| 5 | Communication Services | 11.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Korea Electric Power
KEP
$16B
| $178K | 0.01% |
6,854
-4,043
| -37% | -$104K |
|
327
MSCI
MSCI
$40.9B
| $171K | 0.01% |
2,221
-85
| -4% | -$6.43K |
|
328
SFL Corp
SFL
$1.61B
| $165K | 0.01% |
11,175
-13,228
| -54% | -$197K |
|
329
Interactive Brokers
IBKR
$39.8B
| $150K | 0.01% |
16,940
-644
| -4% | -$6.14K |
|
330
Align Technology
ALGN
$12.3B
| $147K | 0.01% |
+1,831
| New | +$140K |
|
331
D.R. Horton
DHI
$42.3B
| $130K | 0.01% |
4,144
+18
| +0.4% | +$549 |
|
332
Sumitomo Mitsui Financial
SMFG
$164B
| $119K | 0.01% |
20,830
| – | – |
|
333
Hexcel
HXL
$7.82B
| $96K | ﹤0.01% |
2,311
-2,320
| -50% | -$101K |
|
334
Four Corners Property Trust
FCPT
$2.75B
| $42K | ﹤0.01% |
2,028
-87
| -4% | -$1.65K |
|
335
CAE Inc. Common Shares
CAE
$8.74B
| $38K | ﹤0.01% |
+2,440
| New | +$29.5K |
|
336
Itaú Unibanco
ITUB
$87.5B
| $37K | ﹤0.01% |
8,774
| – | – |
|
337
CONMED
CNMD
$1.47B
| $35K | ﹤0.01% |
+730
| New | +$30.9K |
|
338
Sherwin-Williams
SHW
$89.8B
| $35K | ﹤0.01% |
+360
| New | +$35.1K |
|
|
OSB
339
DELISTED
Norbord Inc.
OSB
| $35K | ﹤0.01% |
+1,400
| New | +$29K |
|
340
Essex Property Trust
ESS
$18.5B
| $34K | ﹤0.01% |
+150
| New | +$33.5K |
|
341
Repligen
RGEN
$9.25B
| $34K | ﹤0.01% |
+1,250
| New | +$32K |
|
|
FRP
342
DELISTED
Fairpoint Communications, Inc.
FRP
| $34K | ﹤0.01% |
+2,330
| New | +$32.8K |
|
343
Medtronic
MDT
$112B
| $33K | ﹤0.01% |
+380
| New | +$30.7K |
|
344
AGNC Investment
AGNC
$12.9B
| $32K | ﹤0.01% |
+1,610
| New | +$30.4K |
|
345
The Ensign Group
ENSG
$10.7B
| $32K | ﹤0.01% |
+1,614
| New | +$32.2K |
|
346
Monro
MNRO
$398M
| $32K | ﹤0.01% |
+500
| New | +$33.1K |
|
347
Outfront Media
OUT
$5.5B
| $32K | ﹤0.01% |
+1,351
| New | +$29.6K |
|
348
US Physical Therapy
USPH
$1.22B
| $32K | ﹤0.01% |
+530
| New | +$29.1K |
|
|
VASC
349
DELISTED
Vascular Solutions Inc
VASC
| $32K | ﹤0.01% |
770
-78,841
| -99% | -$2.93M |
|
350
Artivion
AORT
$1.32B
| $31K | ﹤0.01% |
+2,630
| New | +$31K |
|
Similar funds
GIM
PRC
PWS
SCM
IFAM
JWM
TWM
AT
McKinley Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, McKinley Capital Management held 520 positions worth $2.07B, down 0.22% from $2.07B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
McKinley Capital Management's Q2 2016 filing shows 183 new, 97 increased, 159 reduced and 46 closed positions. Its largest new stake was Pfizer: 1,110,190 shares worth $37.1M. The largest sale was Gilead Sciences, an estimated $34.7M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Industrials.
- McKinley Capital Management's largest Q2 2016 buy was Pfizer: 1,110,190 shares worth $37.1M.
- McKinley Capital Management added most to Amazon in Q2 2016, an estimated $30.3M increase.
- McKinley Capital Management's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $34.7M.
- McKinley Capital Management fully exited American International in Q2 2016, selling an estimated $28.8M.
- McKinley Capital Management's ten largest holdings make up 19% of its $2.07B portfolio in Q2 2016.
- McKinley Capital Management opened 183 new positions and closed 46 in Q2 2016.
- McKinley Capital Management's portfolio value fell 0.22% quarter-over-quarter to $2.07B.
Based on McKinley Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.